Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimebon in Moderate-to-Severe Alzheimer's Disease (CONTACT)
NCT00954590Phase 3Terminated
- Sponsor
- Medivation
- Start
- Oct 2009
- Primary completion
- Aug 2010
- Countries
- 2
01
Overview
A Phase 3 trial of latrepirdine in Alzheimer's disease (AD), sponsored by Medivation. Started Oct 2009; status: terminated.
02
Drugs
latrepirdine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00954590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00954590.